Responses
Poster Presentations
Rheumatoid arthritis - anti-TNF therapy
SAT0162 Treatment Target Status at 6 Months and Long-Term Outcomes at 5 Years: Analysis of Methotrexate-Naïve Patients with Rheumatoid Arthritis in the GO-BEFORE Trial
Compose a Response to This Article
Other responses
No responses have been published for this article.